+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade

Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade

Clinical Cancer Research 4(12): 3011-3016

The matrix metalloproteinases (MMPs), in particular the gelatinases (MMP-2 and MMP-9) have been associated with tumor cell invasion and metastasis in many human cancers. Here we examined the expression of proMMP-2 (gelatinase A) and proMMP-9 (gelatinase B) proteins in the cellular component of bladder washes obtained from 65 patients. Twenty-six patients had active bladder cancer, 24 had a history of bladder cancer but no evidence of active disease at the time of cystoscopy (recurrence-free), and 15 patients had lesions other than bladder cancer (controls). The results were correlated with the cytological findings of the bladder wash and the histopathological results of the tumor resection when performed. In patients with active transitional cell carcinoma of the bladder, 71 and 38% had expression and overexpression of the latent form of MMP-9 (proMMP-9), respectively. In contrast, neither latent nor active MMP-2 could be detected in any of the samples examined, regardless of tumor status. Overexpression of proMMP-9 correlated with higher grade (P = 0.003) and pathological stage (P = 0.04) of disease in the active bladder cancer group. No significant gelatinase expression was detected in the recurrence-free and control cases. Compared with urine cytology, proMMP-9 expression had an overall higher sensitivity for bladder cancer identification (71 versus 54%, P = 0.11). Detection of proMMP-9 in bladder washes may be a novel approach for the identification of patients with more aggressive forms of bladder cancer.

(PDF emailed within 1 workday: $29.90)

Accession: 046631281

Download citation: RISBibTeXText

PMID: 9865914

Related references

High levels of matrix metalloproteinase-9 and -2 expression in bladder washes Implication for the diagnosis of bladder cancer. Journal of Urology 157(4 SUPPL ): 11, 1997

Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. Clinical Cancer Research 9(7): 2576-2582, 2003

Telomerase activities in bladder tissues, bladder washes and in urine from patients with transitional cell carcinoma A rapid and non-invasive technique to identify bladder cancer. Clinical Chemistry 43(6 PART 2): S221-S222, 1997

Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder. Urology 61(4): 719-723, 2003

Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. Bju International 108(1): 24-30, 2011

Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma. Journal of Urology 177(3): 1174-1178, 2007

Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 82(7): 1359-1366, April 1, 1998

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer. Bmc Urology 18(1): 97, 2018

Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma. Journal of International Medical Research 39(4): 1381-1391, 2012

Significance of collagenase 3 (matrix metalloproteinase 13) in invasive bladder cancer: correlation with pathological parameters. Urologia Internationalis 78(2): 140-144, 2007

Increased expression of nucleophosmin is associated with worse pathological features and predicts intravesical recurrence in patients with bladder cancer. The Journal of Urology 179(4): 318, 2008

Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resection. Molecular and Clinical Oncology 1(3): 473-479, 2014

Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. Urologic Oncology 32(1): 39.E29-36, 2014

Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. Journal of Urology 171(1): 149-152, 2003

High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clinical Genitourinary Cancer 13(4): E243-E251, 2016